Matinas BioPharma Reports Second Quarter 2021 Financial Results and Operational Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/25/2026

1. QCOM
2. MU
3. CBRS
4. HTZ
5. FDX
6. USO
7. SPY
8. LAES
9. KBH
10. HON

Go back to Matinas BioPharma Reports Second Quarter 2021 Financial Results and Operational Highlights

Matinas BioPharma (MTNB) Tops Q2 EPS by 1c

August 10, 2021 6:34 AM EDT

Matinas BioPharma (NYSE: MTNB) reported Q2 EPS of ($0.02), $0.01 better than the analyst estimate of ($0.03).

For earnings history and earnings-related data on Matinas BioPharma (MTNB) click here.

... More